查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1701379

免疫檢測市場規模、佔有率、趨勢分析報告：按產品、技術、應用、檢體、最終用途、地區和細分市場預測，2025 年至 2030 年

Immunoassay Market Size, Share & Trends Analysis Report By Product, By Technology, By Application, By Specimen, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10個工作天內

價格

免疫檢測市場的成長和趨勢

根據 Grand View Research, Inc. 的新報告，全球免疫檢測市場規模預計到 2030 年將達到 351 億美元，2025 年至 2030 年期間的複合年成長率為 4.59%。

PoC 快速測試和自動免疫檢測分析儀的採用正在推動市場成長。此外，慢性病和感染疾病的增加也推動了市場快速成長。

根據美國癌症協會的數據，2020 年預計將有 1,690 萬名癌症患者/倖存者。根據美國癌症實驗室 2019 年的資料，美國約有 180 萬名癌症患者被診斷出來。根據美國癌症協會的數據，2019 年約有 606,880 人死於癌症。因此，確診癌症病例數量的增加推動了對免疫檢測的需求。預計這將在未來幾年推動市場成長。

此外，人們對感染疾病和預防措施的認知不斷提高，導致對快速診斷測試產品的需求增加，從而促進了銷售。根據世界衛生組織《2018 年世界瘧疾報告》，製造商報告 2017 年橫向流動化驗的銷售額為 2.76 億美元。另據報導，2017 年撒哈拉以南非洲地區約 75.0% 的瘧疾病例是使用橫向流動化驗診斷出來的。

多種基於智慧型手機的設備和相關工具已成為下一代照護現場診斷和測試設備，推動了市場成長。例如，利用智慧型手機應用程式和自主毛細管微流體晶片的組合，可以快速檢測心肌梗塞中的心肌肌鈣蛋白i。該平台在資源有限的環境中易於使用，並可在 12 分鐘內提供測試結果。因此，預計新技術的進步將在預測期內進一步推動市場發展。

西門子醫療有限公司於2018年4月宣佈在美國首次部署採用Aptio自動化技術的Atellica免疫檢測解決方案，該產品旨在促進先進技術產品在美國的傳播。 2020 年 12 月，丹納赫旗下貝克曼庫爾特推出了首個用於 COVID-19 抗原檢測的高品質、高通量檢測方法，正式命名為 Access SARS-CoV-2 抗原檢測方法。 2018 年 7 月，Cygnus Technologies 和 Gyros Protein Technologies 合作生產用於識別生物治療毒素的免疫檢測。兩家公司的策略合作夥伴關係將主要致力於提供生物分析解決方案和簡化生物治療製造。

免疫檢測市場報告重點

  • 到2024年，套件和試劑將以66.10%的佔有率引領市場，這得益於個人化醫療和疾病標靶治療需求的不斷成長。然而，預計免疫檢測領域的軟體和服務在預測期內將以最快的複合年成長率成長，為臨床和研究應用提供測試服務。
  • 免疫檢測產業的感染疾病應用佔據市場主導地位，佔有 66.10% 的佔有率，預計在預測期內的複合年成長率為 5.43%。預計預測期內腫瘤學和自體免疫疾病將顯著成長。
  • 受個人化醫療、癌症診斷、心血管疾病檢測和感染疾病檢測的推動，酵素免疫分析法吸附測定法在 2024 年的市場佔有率達到 63.90%。然而，預計預測期內其他部門的複合年成長率最快。
  • 2024年，血液將佔據最大的市場佔有率，達到41.54%，並且是進行免疫檢測的最大檢體。由於尿液具有非侵入性、易於收集以及在疾病診斷中的廣泛應用，預計它將成為預測期內成長最快的部分。
  • 2024年，醫院在免疫檢測行業的佔有率將達到32.54%。預計預測期內其他產業的複合年成長率為 5.45%。
  • 2024 年，北美免疫檢測市場佔據最大收入佔有率，為 47.43%，主要得益於強大的醫療保健體系、慢性病的高發病率以及對新診斷技術的日益成長的認知。受醫療改革、基礎設施加強和龐大患者群的推動，亞太地區預計將實現最快的複合年成長率。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章免疫檢測市場變數、趨勢與範圍

  • 市場介紹/電網展望
  • 市場規模和成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 免疫檢測市場分析工具
    • 波特五力分析
    • PESTEL分析

第4章免疫檢測市場：按產品的估計和趨勢分析

  • 免疫檢測市場：產品變異分析
  • 按產品 2024 年和 2030 年
  • 檢測試劑套件和試劑
    • ELISA 試劑和套件
    • 快速檢測試劑和套件
    • ELISPOT 試劑與套件
    • 蛋白質印跡試劑和套件
    • 其他試劑和套件
  • 分析設備/測量儀器
    • 開放式系統
    • 封閉式系統
  • 軟體和服務

第5章免疫檢測市場：應用、評估與趨勢分析

  • 免疫檢測市場：應用變異分析
  • 按應用 2024 年和 2030 年
  • 治療產品監測
  • 腫瘤學
  • 心臟病學
  • 內分泌學
  • 傳染病檢查
  • 自體免疫疾病
  • 其他

第6章免疫檢測市場：依技術進行評估與趨勢分析

  • 免疫檢測市場：技術變遷分析
  • 2024年和2030年的技術
  • 免疫檢測（RIA）
  • 酵素免疫分析法（EIA）
    • 化學冷光免疫檢測（CLIA）
    • 螢光免疫分析（FIA）
  • 快速檢測
  • 其他

第7章免疫檢測市場：依檢體、估計和趨勢分析

  • 免疫檢測市場：檢體變異性分析
  • 2024 年和 2030 年的樣本
  • 血
  • 唾液
  • 尿
  • 其他

第 8 章免疫檢測市場：按最終用途、估算和趨勢分析

  • 免疫檢測市場：最終用途變異分析
  • 依2024年及2030年的最終用途
  • 醫院
  • 血庫
  • 臨床實驗室
  • 製藥和生物技術公司
  • 學術研究中心
  • 其他

第9章免疫檢測市場：區域、估計和趨勢分析

  • 2024 年及 2030 年各地區免疫檢測市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司熱圖分析
  • 公司簡介
  • Abbott
  • Siemens Healthineers AG
  • Danaher Corporation（Beckman Coulter）
  • bioMerieux SA
  • Quidel Corporation
  • Sysmex Corporation
  • Ortho Clinical Diagnostics
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Becton, Dickinson, and Company
  • Thermo Fisher Scientific, Inc.
Product Code: GVR-3-68038-066-8

Immunoassay Market Growth & Trends:

The global immunoassay market size is expected to reach USD 35.10 billion by 2030, registering a CAGR of 4.59% from 2025 to 2030, according to a new report by Grand View Research, Inc. The introduction of PoC rapid tests and automated immunoassay analyzers is boosting market growth. In addition, the rising number of chronic and infectious diseases is leading to high market growth.

According to the American Cancer Society, there were an estimated 16.9 million cancer patients/survivors in 2020. Around 1.8 million cancer cases were diagnosed in the U.S., according to the National Cancer Institute 2019 data. According to the American Cancer Society, nearly 606,880 deaths occurred due to cancer in the U.S. in 2019. Thus, the rise in the number of cancer cases being diagnosed is driving the demand for immunoassays. This is expected to boost the market growth in the coming years.

Furthermore, growing awareness regarding infectious diseases and preventive measures has led to a high demand for rapid diagnostic test products, thereby increasing sales. Based on a survey by the WHO on the World malaria report 2018, manufacturers reported sales of 276 million for lateral flow assays in 2017. It also reported that around 75.0% of malaria cases were diagnosed using lateral flow assays in sub-Saharan Africa in 2017.

Several smartphone-based devices and associated tools have emerged as next-generation point-of-care diagnostics or testing devices, thereby boosting the market growth. For instance, a smartphone application combined with the autonomous capillary microfluidic chip is used for the rapid testing of cardiac troponin I in myocardial infarction. This platform can be easily used in resource-limited settings, providing test results within 12 minutes. Thus, novel technological advancements are anticipated to further drive the market over the forecast period.

The first implementation of the Atellica immunoassay solutions with Aptio automation in the United States was announced by Siemens Healthcare GmbH in April 2018. The objective of this product was designed to promote advanced technological products in the U.S. In December 2020, Beckman Coulter, a Danaher business, introduced its first high-quality as well as throughput assay for the COVID-19 antigen detection, officially named Access SARS-CoV-2 Antigen assay. In July 2018, Cygnus Technologies and Gyros Protein Technologies collaborated to produce immunoassay to identify biotherapeutic toxins. The two companies' strategic alliance will primarily focus on offering bioanalytical solutions and increasing biotherapeutics manufacturing efficiencies.

Immunoassay Market Report Highlights:

  • In 2024, kits and reagents led the market with a 66.10% share, driven by increasing demand for personalized medicine and targeted therapies for diseases. However, the software and services of the immunoassays segment is projected to grow at the fastest CAGR during the forecast period and are delivering testing services for clinical and research uses.
  • The infectious disease application in the immunoassay industry led the market with a 66.10% share and is expected to grow at a CAGR of 5.43% over the forecast period. Oncology and autoimmune diseases are projected to grow at a significant growth during the forecast period.
  • Enzyme immunoassays secured the dominant market share in 2024 of 63.90% focusing on personalized medicine, cancer diagnostics, cardiovascular disease testing, and infectious disease detection. However, the others segment is projected to grow at the fastest CAGR during the forecast period.
  • Blood held the largest market share of 41.54% in 2024, being the largest specimen used for performing immunoassays. Urine is expected to be the fastest-growing segment over the forecast period, driven by its non-invasive nature, ease of collection, and widespread application in disease diagnostics.
  • In 2024, the hospitals in the immunoassay industry held a 32.54% share. Others are projected to grow at a CAGR of 5.45% during the forecast period.
  • North America immunoassay market held the largest revenue share at 47.43% in 2024, primarily supported by robust healthcare systems, a high incidence of chronic illnesses, and a growing awareness of new diagnostic technologies. Asia Pacific is set to record the fastest CAGR, propelled by healthcare reforms, infrastructure enhancements, and a large patient pool.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Immunoassay Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Rising incidence of chronic and infectious diseases
      • 3.3.1.2. Increasing demand for point-of-care diagnostics
      • 3.3.1.3. Growing demand for portable and automated immunoassays
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. Lower detection limit
      • 3.3.2.2. Limitations associated with immunoassay techniques
  • 3.4. Immunoassay Market Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Immunoassay Market: Product Estimates & Trend Analysis

  • 4.1. Immunoassay Market: Product Movement Analysis
  • 4.2. Immunoassay Market Estimates and Forecasts, by Product 2024 & 2030 (USD Million)
  • 4.3. Assays, Kits, and Reagents
    • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. ELISA Reagents & Kits
      • 4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Rapid Tests Reagents & Kits
      • 4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. ELISPOT Reagents & Kits
      • 4.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Western Blot Reagents & Kits
      • 4.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.6. Other Reagents & Kits
      • 4.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Analyzers/Instruments
    • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Open Ended Systems
      • 4.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Closed Ended Systems
      • 4.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Software and Services
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Immunoassay Market: Application Estimates & Trend Analysis

  • 5.1. Immunoassay Market: Application Movement Analysis
  • 5.2. Immunoassay Market Estimates and Forecasts, by Application 2024 & 2030 (USD Million)
  • 5.3. Therapeutic Drug Monitoring
    • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cardiology
    • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Endocrinology
    • 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Infectious Disease Testing
    • 5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Autoimmune Diseases
    • 5.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Immunoassay Market: Technology Estimates & Trend Analysis

  • 6.1. Immunoassay Market: Technology Movement Analysis
  • 6.2. Immunoassay Market Estimates and Forecasts, by Technology 2024 & 2030 (USD Million)
  • 6.3. Radioimmunoassay (RIA)
    • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Enzyme Immunoassays (EIA)
    • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Chemiluminescence Immunoassays (CLIA)
      • 6.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Fluorescence Immunoassays (FIA)
      • 6.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Rapid Test
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Immunoassay Market: Specimen Estimates & Trend Analysis

  • 7.1. Immunoassay Market: Specimen Movement Analysis
  • 7.2. Immunoassay Market Estimates and Forecasts, by Specimen 2024 & 2030 (USD Million)
  • 7.3. Blood
    • 7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Saliva
    • 7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Urine
    • 7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Immunoassay Market: End Use Estimates & Trend Analysis

  • 8.1. Immunoassay Market: End--use Movement Analysis
  • 8.2. Immunoassay Market Estimates and Forecasts, by End-use 2024 & 2030 (USD Million)
  • 8.3. Hospitals
    • 8.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Blood Banks
    • 8.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Clinical Laboratories
    • 8.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Pharmaceutical and Biotech Companies
    • 8.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Academic Research Centers
    • 8.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Others
    • 8.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Immunoassay Market: Regional Estimates & Trend Analysis

  • 9.1. Immunoassay Market Share, By Region, 2024 & 2030 (USD Million)
  • 9.2. North America
    • 9.2.1. North America Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Target Disease Prevalence
      • 9.2.2.3. Competitive Scenario
      • 9.2.2.4. Regulatory Framework
      • 9.2.2.5. Reimbursement Scenario
      • 9.2.2.6. U.S. Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Target Disease Prevalence
      • 9.2.3.3. Competitive Scenario
      • 9.2.3.4. Regulatory Framework
      • 9.2.3.5. Reimbursement Scenario
      • 9.2.3.6. Canada Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Target Disease Prevalence
      • 9.2.4.3. Competitive Scenario
      • 9.2.4.4. Regulatory Framework
      • 9.2.4.5. Reimbursement Scenario
      • 9.2.4.6. Mexico Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. Regulatory Framework
      • 9.3.2.5. Reimbursement Scenario
      • 9.3.2.6. UK Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Reimbursement Scenario
      • 9.3.3.6. Germany Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Reimbursement Scenario
      • 9.3.4.6. France Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Target Disease Prevalence
      • 9.3.5.3. Competitive Scenario
      • 9.3.5.4. Regulatory Framework
      • 9.3.5.5. Reimbursement Scenario
      • 9.3.5.6. Italy Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Target Disease Prevalence
      • 9.3.6.3. Competitive Scenario
      • 9.3.6.4. Regulatory Framework
      • 9.3.6.5. Reimbursement Scenario
      • 9.3.6.6. Spain Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Target Disease Prevalence
      • 9.3.7.3. Competitive Scenario
      • 9.3.7.4. Regulatory Framework
      • 9.3.7.5. Reimbursement Scenario
      • 9.3.7.6. Denmark Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Target Disease Prevalence
      • 9.3.8.3. Competitive Scenario
      • 9.3.8.4. Regulatory Framework
      • 9.3.8.5. Reimbursement Scenario
      • 9.3.8.6. Sweden Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Target Disease Prevalence
      • 9.3.9.3. Competitive Scenario
      • 9.3.9.4. Regulatory Framework
      • 9.3.9.5. Reimbursement Scenario
      • 9.3.9.6. Norway Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. Regulatory Framework
      • 9.4.2.5. Reimbursement Scenario
      • 9.4.2.6. Japan Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Reimbursement Scenario
      • 9.4.3.6. China Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. Reimbursement Scenario
      • 9.4.4.6. India Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Reimbursement Scenario
      • 9.4.5.6. Australia Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Reimbursement Scenario
      • 9.4.6.6. South Korea Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Reimbursement Scenario
      • 9.4.7.6. Thailand Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. Regulatory Framework
      • 9.5.2.5. Reimbursement Scenario
      • 9.5.2.6. Brazil Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. Reimbursement Scenario
      • 9.5.3.6. Argentina Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. Regulatory Framework
      • 9.6.2.5. Reimbursement Scenario
      • 9.6.2.6. South Africa Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Reimbursement Scenario
      • 9.6.3.6. Saudi Arabia Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Target Disease Prevalence
      • 9.6.4.3. Competitive Scenario
      • 9.6.4.4. Regulatory Framework
      • 9.6.4.5. Reimbursement Scenario
      • 9.6.4.6. UAE Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Target Disease Prevalence
      • 9.6.5.3. Competitive Scenario
      • 9.6.5.4. Regulatory Framework
      • 9.6.5.5. Reimbursement Scenario
      • 9.6.5.6. Kuwait Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Heat Map Analysis
  • 10.4. Company Profiles
  • 10.5. Abbott
    • 10.5.1. Participant's Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Developments/ Strategic Initiatives
  • 10.6. Siemens Healthineers AG
    • 10.6.1. Participant's Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Developments/ Strategic Initiatives
  • 10.7. Danaher Corporation (Beckman Coulter)
    • 10.7.1. Participant's Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Developments/ Strategic Initiatives
  • 10.8. bioMerieux SA
    • 10.8.1. Participant's Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Developments/ Strategic Initiatives
  • 10.9. Quidel Corporation
    • 10.9.1. Participant's Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Developments/ Strategic Initiatives
  • 10.10. Sysmex Corporation
    • 10.10.1. Participant's Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Developments/ Strategic Initiatives
  • 10.11. Ortho Clinical Diagnostics
    • 10.11.1. Participant's Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Developments/ Strategic Initiatives
  • 10.12. Bio-Rad Laboratories, Inc.
    • 10.12.1. Participant's Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Developments/ Strategic Initiatives
  • 10.13. F. Hoffmann-La Roche AG
    • 10.13.1. Participant's Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Developments/ Strategic Initiatives
  • 10.14. Becton, Dickinson, and Company
    • 10.14.1. Participant's Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Developments/ Strategic Initiatives
  • 10.15. Thermo Fisher Scientific, Inc.
    • 10.15.1. Participant's Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global immunoassay market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 7 Global immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 North America immunoassay market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 10 North America immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 12 North America immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 13 North America immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 15 U.S. immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 16 U.S. immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 17 U.S. immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 18 U.S. immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Canada immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 20 Canada immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 21 Canada immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Canada immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 23 Canada immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Mexico immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 25 Mexico immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 26 Mexico immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Mexico immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 28 Mexico immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Europe immunoassay market, by country, 2018 - 2030 (USD Million)
  • Table 30 Europe immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 31 Europe immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 32 Europe immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Europe immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 34 Europe immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 UK immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 36 UK immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 37 UK immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 38 UK immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 39 UK immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Germany immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 41 Germany immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 42 Germany immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Germany immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 44 Germany immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 France immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 46 France immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 47 France immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 48 France immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 49 France immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Italy immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 51 Italy immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 52 Italy immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 53 Italy immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 54 Italy immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Spain immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 56 Spain immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 57 Spain immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Spain immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 59 Spain immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Denmark immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 61 Denmark immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 62 Denmark immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Denmark immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 64 Denmark immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Sweden immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 66 Sweden immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 67 Sweden immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Sweden immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 69 Sweden immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Norway immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 71 Norway immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 72 Norway immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 73 Norway immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 74 Norway immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific immunoassay market, by country, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 81 Japan immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 82 Japan immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 83 Japan immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Japan immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 85 Japan immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 China immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 87 China immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 88 China immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 89 China immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 90 China immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 India immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 92 India immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 93 India immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 94 India immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 95 India immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 Australia immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 97 Australia immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 98 Australia immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 99 Australia immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 100 Australia immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 101 South Korea immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 102 South Korea immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 103 South Korea immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 104 South Korea immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 105 South Korea immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 106 Thailand immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 107 Thailand immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 108 Thailand immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 109 Thailand immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 110 Thailand immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 111 Latin America immunoassay market, by country, 2018 - 2030 (USD Million)
  • Table 112 Latin America immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 113 Latin America immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 114 Latin America immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 115 Latin America immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 116 Latin America immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 117 Brazil immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 118 Brazil immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 119 Brazil immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 120 Brazil immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 121 Brazil immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 122 Argentina immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 123 Argentina immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 124 Argentina immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 125 Argentina immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 126 Argentina immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 127 MEA immunoassay market, by country, 2018 - 2030 (USD Million)
  • Table 128 MEA immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 129 MEA immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 130 MEA immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 131 MEA immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 132 MEA immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 133 South Africa immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 134 South Africa immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 135 South Africa immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 136 South Africa immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 137 South Africa immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 143 UAE immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 144 UAE immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 145 UAE immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 146 UAE immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 147 UAE immunoassay market, by end-use, 2018 - 2030 (USD Million)
  • Table 148 Kuwait immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 149 Kuwait immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 150 Kuwait immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 151 Kuwait immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 152 Kuwait immunoassay market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Immunoassay market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Immunoassay market: Product outlook key takeaways
  • Fig. 20 Immunoassay market: Product movement analysis
  • Fig. 21 Assays, kits, and reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 ELISA Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Rapid Tests Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 ELISPOT Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Western Blot Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Other Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Analyzers/Instruments and systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Software and services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Open Ended Systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Closed Ended Systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Immunoassay market: Application outlook key takeaways
  • Fig. 32 Immunoassay market: Application movement analysis
  • Fig. 33 Therapeutic Drug Monitoring
  • Fig. 34 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Endocrinology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Infectious Disease Testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Autoimmune Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Immunoassay market: Technology outlook key takeaways
  • Fig. 41 Immunoassay market: Technology movement analysis
  • Fig. 42 Radioimmunoassay (RIA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Enzyme Immunoassays (EIA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Rapid Test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Chemiluminescence Immunoassays (CLIA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Fluorescence Immunoassays (FIA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Immunoassay market: Specimen outlook key takeaways
  • Fig. 49 Immunoassay market: Specimen movement analysis
  • Fig. 50 Blood market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Saliva market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Urine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Immunoassay market: End-use outlook key takeaways
  • Fig. 55 Immunoassay market: End-use movement analysis
  • Fig. 56 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Blood Banks market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Clinical Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Pharmaceutical and Biotech Companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Academic Research Centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Regional marketplace outlook, 2024 & 2030 (USD Million)
  • Fig. 63 Regional marketplace: Key takeaways
  • Fig. 64 North America immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 U.S. immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Canada immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Mexico immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Europe immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 UK immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Germany immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 France immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Spain immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Italy immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Denmark immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Sweden immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Norway immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Asia Pacific immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Japan immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 China immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 India immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Australia immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 South Korea immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Thailand immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 Market participant categorization
  • Fig. 103 Immunoassay market position analysis, 2023
  • Fig. 104 Strategic framework